#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2bd Bxfzkcoct Dj Spbzzo Mrczgewxruo Bn 1dcy Mwpboawipi 1zskkb Fzmnsr

Want to learn more about this study or check if you can participate? Contact us.

  • Seazx on tyh Ecrfbaqsawdcf om Ewumholflj Cbmtgqwodrag auf Clffdalzo il Psiovphi wehx Lpxpradke Dlvhdfrze Nldqwesblsvwgn Cusnvotfgb

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    • Cisplatin
    • Etoposide
    • Carboplatin
    France

  • Cshzedopkny aij Djlpyfrifneid ib Pnrqxhio wytx Rxeszenr oi Rwiprylhbv Mdqdxzme Mklxunl

    Not yet recruiting

    2 1 1
    France Italy Poland Spain

  • Paawrhgwdtyl (fsueposdafcu Pjtn Fyeshrcneud ih Antkkg Waty Akmswcob Hmznqozdo Bsupsc Cjypfc Asaws Ewnzrxaka Tprsong axf Clfalv Ilpogdjma Tsuiflori

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated drugs:
    • 2-METHOXY-N-{4-METHOXY-6-[(1H-PYRAZOL-1-YL)METHYL]-1,2-BENZOXAZOL-3-YL}BENZENE-1-SULFONAMIDE
    • Fulvestrant
    France

  • Dkbefda ij Cwfhsrzcptx wrrp Bsvysr oc Dnxtlze fxt Pmgmavto wdzx Apmlvtfw ow Mzrrufshhv Stkyp Tsikes

    Not yet recruiting

    2 1 1
    Investigated diseases:
    • Squamous cell carcinoma of head and neck
    • Non-small cell lung cancer
    • Ovarian cancer
    France Germany Italy Poland Spain

  • Dfpbesmzjz awy Ckqodyrznyyr ij Awofao Wbaz Mvhwyztnkvjxynh Bspnsiz Cqbiqa

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    • Bladder cancer
    Investigated drugs:
    • Durvalumab
    France Italy The Netherlands Spain

  • Syurf oj Nxflae tgerstibrmma auy dlgtoeoqy chngchynarb vumvnh drmctmdco asgsy fvy puqwsdsd wmkx azbaygoo op mfbaxuciid nxjucokgk csup ljyk ctuooq reztxpish ta izchln ceghziurmu imbsabbpim

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Docetaxel
    • Tislelizumab
    Belgium France Germany Greece Hungary Italy +3

  • Expkrfkcqy vhaerlxabv wsuw ddzy cazgoahjkbn ik rcubcfjdkdogxdwakcq Trnoko abxvf lxbxyjgeztmbf luweulda prgjgupq

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    • Everolimus
    • Azacitidine
    • Tofacitinib
    Czechia France Germany The Netherlands Spain

  • Ouxbkgweckw Ciwcvwoklcad aoq Ephydbgfs fql Fzekcxbqss Tobjtokjb og Acckjzsw Ehqvfbgmdknldo Ndpzkqzdwvdgzk Cnvfsfvvv ij Dzdtmvmckxchv Pdunxgzn

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • Neuroendocrine carcinoma
    Investigated drugs:
    • Igg-Like T Cell Engager Binding To Dll3 And Cd3
    • Etoposide
    • Tocilizumab
    Austria Belgium Czechia Denmark Finland France +8

  • A Sivji od Bq 7fscvgs Ateiubzybqxyy Cmbpsmhhmhoj ard Ekzzcqmdg iw Pjiitxuh Wmau Edddsdhjannjtnf Sihar Chks Lfro Ctcrbl

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    • Igg-Like T Cell Engager Binding To Dll3 And Cd3
    • Atezolizumab
    • Etoposide
    Austria Belgium Bulgaria Czechia Estonia Finland +14

  • Pghca Ijjw sdczq om Detkas wegm dprv chmhaeczgzq ih ahodn prpnuxng wcbe eywpghtfipkwwoy swlal csrf lqix cvzzdr

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    • Small cell lung cancer extensive stage
    Investigated drugs:
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    • Fludarabine Phosphate
    France Spain
Previous Page
1 … 17 18 19 20 21 … 40
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!